JD HEALTH INTERNATIONAL INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.6 HKD | +7.26% |
|
+16.41% | -31.97% |
| Apr. 11 | China stocks rise as commodities shine; Hong Kong snaps winning streak | RE |
| Apr. 03 | Alibaba Health Refutes Rumors of Purchase of Telemedicine Platform HaoDF | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 402,020 | 159,955 | 200,382 | 78,525 | 78,525 | - |
| Enterprise Value (EV) 1 | 369,839 | 118,166 | 154,618 | 113,318 | 57,609 | 50,111 |
| P/E ratio | -16.2 x | -143 x | 525 x | 52.3 x | 32.7 x | 24.8 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 20.7 x | 5.21 x | 4.29 x | 2.12 x | 1.26 x | 1.08 x |
| EV / Revenue | 19.1 x | 3.85 x | 3.31 x | 2.12 x | 0.93 x | 0.69 x |
| EV / EBITDA | 976 x | -90.7 x | 877 x | 122 x | 32.6 x | 18 x |
| EV / FCF | 101 x | 40.5 x | 26.4 x | 11.8 x | 12.4 x | 8.04 x |
| FCF Yield | 0.99% | 2.47% | 3.79% | 8.45% | 8.08% | 12.4% |
| Price to Book | 7.1 x | 3.89 x | 4.37 x | 1.65 x | 1.49 x | 1.37 x |
| Nbr of stocks (in thousands) | 3,184,367 | 3,194,617 | 3,179,915 | 3,189,115 | 3,189,115 | - |
| Reference price 2 | 126.2 | 50.07 | 63.01 | 24.62 | 24.62 | 24.62 |
| Announcement Date | 3/29/21 | 3/28/22 | 3/22/23 | 3/20/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 10,842 | 19,383 | 30,682 | 46,736 | 53,530 | 62,111 | 72,716 |
| EBITDA 1 | - | 378.9 | -1,303 | 176.3 | 928.2 | 1,766 | 2,782 |
| EBIT 1 | - | 351.7 | -1,366 | 35.6 | 894.4 | 1,545 | 2,593 |
| Operating Margin | - | 1.81% | -4.45% | 0.08% | 1.67% | 2.49% | 3.57% |
| Earnings before Tax (EBT) 1 | - | -17,072 | -901.5 | 695.8 | 2,693 | 2,940 | 3,902 |
| Net income 1 | -971.8 | -17,234 | -1,074 | 380.1 | 2,142 | 2,410 | 3,184 |
| Net margin | -8.96% | -88.92% | -3.5% | 0.81% | 4% | 3.88% | 4.38% |
| EPS 2 | - | -7.800 | -0.3500 | 0.1200 | 0.6800 | 0.7533 | 0.9922 |
| Free Cash Flow 1 | - | 3,662 | 2,921 | 5,865 | 4,760 | 4,656 | 6,237 |
| FCF margin | - | 18.89% | 9.52% | 12.55% | 8.95% | 7.5% | 8.58% |
| FCF Conversion (EBITDA) | - | 966.35% | - | 3,327.11% | 327.4% | 263.63% | 224.17% |
| FCF Conversion (Net income) | - | - | - | 1,542.99% | 222.68% | 193.21% | 195.85% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 11/25/20 | 3/29/21 | 3/28/22 | 3/22/23 | 3/20/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 10,605 | 13,638 | 17,044 | 20,225 | 26,511 | 13,160 | 27,110 | 11,361 | 14,797 | 26,420 | 28,988 | 32,172 |
| EBITDA | - | - | -771.1 | - | - | - | - | - | - | - | - | - |
| EBIT 1 | - | 597.4 | -808.5 | 1,201 | -185.6 | - | 943.9 | 636 | 298 | -243.2 | - | - |
| Operating Margin | - | 4.38% | -4.74% | 5.94% | -0.7% | - | 3.48% | 5.6% | 2.01% | -0.92% | - | - |
| Earnings before Tax (EBT) | - | - | -556.2 | 377.3 | 318.5 | - | 1,831 | - | - | 862.1 | - | - |
| Net income | - | -454.2 | -618.4 | 223 | 157.1 | - | 1,561 | - | - | 580.5 | 1,076 | 1,030 |
| Net margin | - | -3.33% | -3.63% | 1.1% | 0.59% | - | 5.76% | - | - | 2.2% | 3.71% | 3.2% |
| EPS | - | - | - | 0.0700 | 0.0500 | - | 0.4900 | - | - | 0.1900 | 0.3400 | 0.3200 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/29/21 | 8/24/21 | 3/28/22 | 8/23/22 | 3/22/23 | 8/16/23 | 8/16/23 | - | - | 3/20/24 | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 32,181 | 41,789 | 45,764 | 22,172 | 20,916 | 28,414 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 3,662 | 2,921 | 5,865 | 4,760 | 4,656 | 6,237 |
| ROE (net income / shareholders' equity) | - | 3.86% | -2.71% | 0.9% | 5.99% | 5.88% | 6.93% |
| ROA (Net income/ Total Assets) | - | 2.85% | -2.33% | 0.7% | 3.16% | 3.08% | 3.87% |
| Assets 1 | - | -605,613 | 45,998 | 54,639 | 67,706 | 78,243 | 82,229 |
| Book Value Per Share 2 | - | 17.80 | 12.90 | 14.40 | 14.90 | 16.50 | 17.90 |
| Cash Flow per Share 2 | - | 1.680 | 1.110 | 1.880 | 1.430 | 1.570 | 1.940 |
| Capex 1 | - | 37.6 | 502 | 40.2 | 175 | 187 | 209 |
| Capex / Sales | - | 0.19% | 1.64% | 0.09% | 0.33% | 0.3% | 0.29% |
| Announcement Date | 11/25/20 | 3/29/21 | 3/28/22 | 3/22/23 | 3/20/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
24.62
CNY
Average target price
40.01
CNY
Spread / Average Target
+62.51%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -31.97% | 10.84B | |
| -32.21% | 15.27B | |
| -30.42% | 6.06B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -0.88% | 4.71B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B |
- Stock Market
- Equities
- 6618 Stock
- Financials JD Health International Inc.
